abs218.txt	in	desmoplastic	melanoma		tumor	cells	and	tumor-associated	fibroblasts	are	themajor	dominators	playing	a	critical	role	the	fibrosis	morphology	as	well	asthe	immunosuppressive	microenvironment	(tme)	compromising	efficacy	oftherapeutic	options	to	overcome	this	therapeutic	hurdle	we	developed	aninnovative	chemo-immunostrategy	based	on	targeted	delivery	of	mitoxantrone	(mit)and	celastrol	(cel)	two	potent	medicines	screened	selected	with	bestanticancer	antifibrosis	potentials	importantly	cel	worked	synergy	withmit	induce	immunogenic	cell	death	here	show	that	when	effectivelyco-delivered	site	at	their	optimal	ratio	by	tme-responsivenanocarrier	5	1	combination	mit	significantly	triggeredimmunogenic	apoptosis	recovered	antigen	recognition	thuseliciting	overall	antitumor	immunity	furthermore	strong	benefittedthe	host	reduced	drug	exposure	side	effects	collectively	thenanocarrier-mediated	chemo-immunotherapy	successfully	remodeled	fibrotic	andimmunosuppressive	tme	arrested	cancer	progression	further	inhibited	tumormetastasis	major	organs	affected	tumors	remained	dormant	long	afterdosing	stopped	resulting	prolonged	progression-free	survival	sustainedimmune	surveillance	bearing
